{
    "Trade/Device Name(s)": [
        "CAPILLARYS IMMUNOTYPING",
        "IT / IF CONTROL",
        "CAPILLARYS 2",
        "CAPILLARYS 2 FLEX PIERCING"
    ],
    "Submitter Information": "Sebia",
    "510(k) Number": "K130500",
    "Predicate Device Reference 510(k) Number(s)": [
        "K960669",
        "K042939",
        "K082085",
        "K101863",
        "K002799"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFF",
        "DFH",
        "DEH",
        "CEF",
        "JJY"
    ],
    "Summary Letter Date": "July 22, 2013",
    "Summary Letter Received Date": "July 25, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, and E immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Immunoglobulin G",
        "Immunoglobulin A",
        "Immunoglobulin M",
        "Kappa light chain",
        "Lambda light chain"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CAPILLARYS 2",
        "CAPILLARYS 2 FLEX PIERCING",
        "MINICAP",
        "HYDRASYS",
        "HYDRASYS 2",
        "K20 electrophoresis chamber"
    ],
    "Method(s)/Technology(ies)": [
        "Capillary electrophoresis",
        "Immunofixation"
    ],
    "Methodologies": [
        "Protein separation",
        "Electrophoretic detection",
        "Qualitative analysis"
    ],
    "Submission Type(s)": [
        "Kit",
        "Control",
        "Instrument",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Sebia CAPILLARYS IMMUNOTYPING kit and IT/IF CONTROL using CAPILLARYS 2 and CAPILLARYS 2 FLEX PIERCING instruments for monoclonal protein detection in serum and urine via capillary electrophoresis.",
    "Indications for Use Summary": "Designed for detection and characterization of monoclonal proteins (immunotyping) in human urine and serum using CAPILLARYS 2 and CAPILLARYS 2 FLEX PIERCING instruments; IT / IF Control is for quality control of immunoglobulin detection using electrophoresis methods.",
    "fda_folder": "Clinical Chemistry"
}